
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [MRSN] Mersana Therapeutics Inc
Data updated 2025-Apr-11 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Apr-11 Friday
Open | $0.26 | High | $0.31 +18.14% |
---|---|---|---|
Close | $0.31 | Low | $0.26 0.00% |
Volume | 2.61 Million 0.98x | Volatility | 18.14% |
Change |
+$0.05
+18.94%
|
Streak | ↑ 1 days +18.94% |
20d SMA | $0.37 -16.3% | 50d SMA | $0.49 -36.3% | 100d SMA | $1.03 -69.9% | 200d SMA | $1.46 -78.6% |
RSI | 36 | MACD | 0.0 | ADX | 51.9 | Stochastic Oscillator | 15.9 14.7 |
CCI | -88.5 | ATR | 0.05 | OBV | -145 Million | Chaikin A/D | 27.8 Million |
Market Cap | 497 M | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 12.9 | Price/Book (mrq) | 13.5 | EV/Revenue (ttm) | 8.73 | EV/EBITDA (ttm) | -1.94 |
% Held by Insiders | 1.33% | % Held by Institutions | 95.90% | Shares Short | 8.73 M | Shares Short (prior month) | 7.1 M |
Short Ratio | 3.03 | Short % of Outstanding | 7.20% | Short % of Float | 13.57% | Shares Short Change (mom) | +23.0% |
Revenue/Share (ttm) | $0.32 | Profit Margin (ttm) | 0.00% | Operating Margin (ttm) | -195.57% | EBITDA (ttm) | -169 M |
Diluted EPS (ttm) | $-1.48 | Current Ratio (mrq) | 3.36 | Return on Assets (ttm) | -38.13% | Return on Equity (ttm) | -266.24% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | -27.10% | Operating Cash Flow (ttm) | -169 M | Free Cash Flow (ttm) | -85.7 M | |
Choose view type
Daily Performance for Mersana Therapeutics Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Mersana Therapeutics Inc up to close of 2025-Apr-11 at $0.31
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+2.64%
|
-9.3%
|
+20.1%
|
30.8%
|
+5.5%
|
+3.7%
|
0.98x
|
02 Trailing 10-days
|
|
-18.08%
|
-18.1%
|
+20.1%
|
46.2%
|
+0.3%
|
-2.7%
|
0.94x
|
03 Trailing 20-days
|
|
-33.13%
|
-36.3%
|
+20.1%
|
88.5%
|
-16.3%
|
-14.9%
|
0.84x
|
04 Trailing 30-days
|
|
-40.60%
|
-43.9%
|
+20.1%
|
111.5%
|
-24.8%
|
-25.2%
|
0.84x
|
05 Trailing 50-days
|
|
-51.17%
|
-62.0%
|
+20.1%
|
215.4%
|
-36.3%
|
-43.3%
|
0.89x
|
06 Trailing 100-days
|
|
-87.66%
|
-89.0%
|
+20.1%
|
988.5%
|
-69.9%
|
-65.3%
|
1.59x
|
07 Trailing 200-days
|
|
-85.20%
|
-89.0%
|
+20.1%
|
988.5%
|
-78.6%
|
-78.0%
|
1.07x
|
08 Month-to-date
|
|
-9.67%
|
-16.0%
|
+20.1%
|
42.3%
|
|
|
|
09 Quarter-to-date
|
|
-9.67%
|
-16.0%
|
+20.1%
|
42.3%
|
|
|
|
10 Year-to-date
|
|
-78.26%
|
-79.5%
|
+20.1%
|
484.6%
|
|
|
|
11 Trailing 52-weeks
|
|
-91.64%
|
-92.1%
|
+20.1%
|
1,423.1%
|
|
|
|
3-month Performance Benchmarks for Mersana Therapeutics Inc:
Related to Mersana Therapeutics Inc
Information for Mersana Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-11 on Google
SEC Reports : Quarterly reports around 2025-Apr-11 on SEC Edgar
Compare Mersana Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Mersana Therapeutics Inc
Industry : Biotechnology industry performance which includes Mersana Therapeutics Inc